Hodgkin lymphoma (HL) is characterized by a minority of tumor cells located within an abundant infiltrate consisting of various types of inflammatory cells. ?e scarce tumor cells survive this hostile environment by producing immune suppressive factors and attracting specific non-hostile infiltrating cell populations [1]. However, it is likely that additional mechanisms are involved. In this thesis, we investigated the role of the HGF/c-Met signaling pathway and several other factors that can modulate the anti-tumor immune response, i.e. expression of toll like receptors (TLRs), functionality of HLA class II, expression of CD1 molecules and presence of invariant natural killer T (iNKT) cells. Zie: Chapter 6
Abstract Inappropriate activation of c-mesenchymal-epithelial transition (MET), the receptor tyrosin...
Classical Hodgkin’s lymphoma (cHL) accounts for 10% of all lymphoma diagnosis. The peculiar feature ...
Hodgkin lymphoma (HL) is characterized by a minority of Hodgkin and Reed-Sternberg (HRS) cells in a ...
Tumor cell survival and immune escape mechanisms in classical Hodgkin lymphoma The nature of classic...
Classical Hodgkin lymphoma (cHL) is characterized by a minority of tumor cells derived from germinal...
Classical Hodgkin lymphoma (cHL) is characterized by a minority of tumor cells derived from germinal...
It has become clear that cancer is not merely a growth of autonomously proliferating cells, but that...
Background: Hodgkin's lymphoma (HL) is characterized by a minority of neoplastic cells, the so-calle...
An understanding of interactions within the tumor microenvironment (TME) of classic Hodgkin lymphoma...
Copyright © 2012 Luis de la Cruz-Merino et al. This is an open access article distributed under the ...
Classic Hodgkin lymphoma (cHL) is characterized by a few tumor cells surrounded by a protective, imm...
Journal Article; Review;Hodgkin's lymphoma represents one of the most frequent lymphoproliferative s...
Accumulating data suggest that tumor-induced immune dysfunction counteracts presumptively efficient ...
In 1909, Paul Ehrlich first suggested that the immune system protects against cancer. Over a century...
Hodgkin lymphoma (HL) is characterized by a minority of Hodgkin and Reed-Sternberg (HRS) cells in a ...
Abstract Inappropriate activation of c-mesenchymal-epithelial transition (MET), the receptor tyrosin...
Classical Hodgkin’s lymphoma (cHL) accounts for 10% of all lymphoma diagnosis. The peculiar feature ...
Hodgkin lymphoma (HL) is characterized by a minority of Hodgkin and Reed-Sternberg (HRS) cells in a ...
Tumor cell survival and immune escape mechanisms in classical Hodgkin lymphoma The nature of classic...
Classical Hodgkin lymphoma (cHL) is characterized by a minority of tumor cells derived from germinal...
Classical Hodgkin lymphoma (cHL) is characterized by a minority of tumor cells derived from germinal...
It has become clear that cancer is not merely a growth of autonomously proliferating cells, but that...
Background: Hodgkin's lymphoma (HL) is characterized by a minority of neoplastic cells, the so-calle...
An understanding of interactions within the tumor microenvironment (TME) of classic Hodgkin lymphoma...
Copyright © 2012 Luis de la Cruz-Merino et al. This is an open access article distributed under the ...
Classic Hodgkin lymphoma (cHL) is characterized by a few tumor cells surrounded by a protective, imm...
Journal Article; Review;Hodgkin's lymphoma represents one of the most frequent lymphoproliferative s...
Accumulating data suggest that tumor-induced immune dysfunction counteracts presumptively efficient ...
In 1909, Paul Ehrlich first suggested that the immune system protects against cancer. Over a century...
Hodgkin lymphoma (HL) is characterized by a minority of Hodgkin and Reed-Sternberg (HRS) cells in a ...
Abstract Inappropriate activation of c-mesenchymal-epithelial transition (MET), the receptor tyrosin...
Classical Hodgkin’s lymphoma (cHL) accounts for 10% of all lymphoma diagnosis. The peculiar feature ...
Hodgkin lymphoma (HL) is characterized by a minority of Hodgkin and Reed-Sternberg (HRS) cells in a ...